Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers discover new disorder that causes chronic diarrhea in children

20.07.2006
Discovery may help further stem cell research for type I diabetes and intestinal disorders

UCLA researchers have unraveled a mysterious condition that causes congenital diarrhea and intestinal failure in children. The new disorder, named enteric anendocrinosis, is caused by a mutation in the gene Neurogenin-3 (NEUROG3).

The findings represent the first description of a disease-causing mutation of NEUROG3 in humans and the first new discovery within the past 15 years of a disorder that causes intestinal failure.

Patients with this condition have an abnormally low number of endocrine cells in their intestine and also eventually develop type I diabetes.

"Rare diseases help us understand how the body works," said principal investigator, Dr. Martín G. Martín, professor of pediatrics in the division of gastroenterology and nutrition at Mattel Children's Hospital at UCLA. "We now know that the hormone-producing endocrine cells of the intestine have an essential role in facilitating nutrient absorption. These findings have already led to the detection of subset forms of enteric anendocrinosis."

Martín and his colleagues describe their research in the July 20 issue of the peer-reviewed New England Journal of Medicine.

The study focuses on three children who each showed symptoms of vomiting, diarrhea and dehydration during the first few weeks of life, following consumption of formula.

Researchers used genomic DNA from the patients to screen for mutations of NEUROG3. They then tested the ability of the mutations to alter NEUROG3's function.

Martín anticipates that this discovery will provide the framework to further understand type I diabetes, as well as other diarrheal disorders, including inflammatory bowel disease and diarrhea-predominant irritable bowel syndrome.

"Since patients with enteric anendocrinosis develop type I diabetes, we hope stem cell researchers can apply the knowledge from this discovery to the role of NEUROG3 in the development of insulin-producing islet cells in the pancreas," Martín said.

"In mice, Neurogenin-3 initiates the development of the endocrine cells in the pancreas, including the insulin-producing cells," said Dr. Michael German, professor of medicine at the University of California, San Francisco, Hormone Research Institute. "In the absence of Neurogenin-3, no insulin-producing cells are generated in the pancreas, and the animals develop diabetes at birth. Therefore, Neurogenin-3 has been termed a 'pro-endocrine' gene, since it drives progenitor cells to mature into endocrine cells."

"The cure for enteric anendocrinosis and diabetes--two diseases that involve failure of a specific type of cell--may eventually be derived from stem cells that are able to replace the dysfunctional cells and produce the right kind of hormones," said Dr. Doron Kahana, a pediatric gastroenterology research fellow in Martín's lab.

There are about 30 known causes of chronic diarrhea. It affects approximately 5 percent of the population and only rarely occurs during the first several weeks of life.

Unlike acute diarrhea--which is normally caused by a virus, bacteria or parasite and generally improves within a few days or weeks--chronic diarrhea persists and can lead to severe malnutrition and growth failure in children.

For newborns with enteric anendocrinosis, their condition is worsened by eating. Treatment usually involves specialized formulas and intravenous nutrition to minimize the diarrheal symptoms and promote growth. Currently, there is no cure for the illness.

Amy Waddell Albin | EurekAlert!
Further information:
http://www.mednet.ucla.edu

More articles from Life Sciences:

nachricht Molecular Force Sensors
20.09.2017 | Max-Planck-Institut für Biochemie

nachricht Foster tadpoles trigger parental instinct in poison frogs
20.09.2017 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>